Q1 2017 13F Holders as of 31 Mar 2017
-
Type / Class
-
Equity / ORD SHS
-
Total 13F shares
-
20,037,814
-
Share change
-
+2,735,590
-
Total reported value
-
$310,385,115
-
Price per share
-
$15.49
-
Number of holders
-
78
-
Value change
-
+$42,450,531
-
Number of buys
-
46
-
Number of sells
-
25
Institutional Holders of OXFORD IMMUNOTEC GLOBAL PLC - ORD SHS (OXFD) as of Q1 2017
As of 31 Mar 2017,
OXFORD IMMUNOTEC GLOBAL PLC - ORD SHS (OXFD) was held by
78 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,037,814 shares.
The largest 10 holders included
Polar Capital LLP, Redmile Group, LLC, Invesco Ltd., New Leaf Venture Partners, L.L.C., BlackRock Inc., Alyeska Investment Group, L.P., AXA, PRICE T ROWE ASSOCIATES INC /MD/, Grandeur Peak Global Advisors, LLC, and First Light Asset Management, LLC.
This page lists
78
institutional shareholders reporting positions in this security
for the Q1 2017 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.